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Abstract
Background: Ovarian cancer is characterized by a wide-spread intra-abdominal metastases which represents a major
clinical hurdle in the prognosis and management of the disease. A significant proportion of ovarian cancer cells in
peritoneal ascites exist as multicellular aggregates or spheroids. We hypothesize that these cellular aggregates or
spheroids are invasive with the capacity to survive and implant on the peritoneal surface. This study was designed to
elucidate early inherent mechanism(s) of spheroid survival, growth and disaggregation required for peritoneal metastases
Methods: In this study, we determined the growth pattern and adhesive capacity of ovarian cancer cell lines (HEY and
OVHS1) grown as spheroids, using the well established liquid overlay technique, and compared them to a normal ovarian
cell line (IOSE29) and cancer cells grown as a monolayer. The proteolytic capacity of these spheroids was compared with
cells grown as a monolayer using a gelatin zymography assay to analyze secreted MMP-2/9 in conditioned serum-free
medium. The disaggregation of cancer cell line spheroids was determined on extracellular matrices (ECM) such as laminin
(LM), fibronectin (FN) and collagen (CI) and the expression of α2, α3, αv, α6 and β1 interin was determined by flow
cytometric analysis. Neutralizing antibodies against α2, β1 subunits and α2β1 integrin was used to inhibit disaggregation
as well as activation of MMPs in spheroids.
Results: We demonstrate that ovarian cancer cell lines grown as spheroids can sustain growth for 10 days while the
normal ovarian cell line failed to grow beyond 2 days. Compared to cells grown as a monolayer, cancer cells grown as
spheroids demonstrated no change in adhesion for up to 4 days, while IOSE29 cells had a 2–4-fold loss of adhesion within
2 days. Cancer cell spheroids disaggregated on extracellular matrices (ECM) and demonstrated enhanced expression of
secreted pro-MMP2 as well as activated MMP2/MMP9 with no such activation of MMP's observed in monolayer cells.
Flow cytometric analysis demonstrated enhanced expression of α2 and diminution of α6 integrin subunits in spheroids
versus monolayer cells. No change in the expression of α3, αv and β1 subunits was evident. Conversely, except for αv
integrin, a 1.5–7.5-fold decrease in α2, α3, α6 and β1 integrin subunit expression was observed in IOSE29 cells within 2
days. Neutralizing antibodies against α2, β1 subunits and α2β1 integrin inhibited disaggregation as well as activation of
MMPs in spheroids.
Conclusion: Our results suggest that enhanced expression of α2β1 integrin may influence spheroid disaggregation and
proteolysis responsible for the peritoneal dissemination of ovarian carcinoma. This may indicate a new therapeutic target
for the suppression of the peritoneal metastasis associated with advanced ovarian carcinomas.
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Background
'It is not the strongest of the species that survive, or the
most intelligent, but the one most responsive to change'–
Charles Darwin. Cancer cells are very responsive to their
microenvironment and have been shown to acquire resist-
ance in response to physical and chemical stress associ-
ated with the changed microenvironment [1]. The vast
majority (~90%) of ovarian cancer arises from the malig-
nant transformation of the ovarian surface epithelium
[2,3]. This transformation leads to altered adhesion of
transformed cells, which in turn results in the shedding of
tumor cells into the peritoneal cavity where they float in
the peritoneal fluid or ascites as clumps of aggregated cells
or spheroids until they find a secondary attachment site
for further growth. Even though the attachment of shed
floating spheroids to the peritoneal lining and associated
organs is the major route for the dissemination of ovarian
carcinoma [4], research in ovarian cancer has focused
mainly on the metastatic behavior of single cells and little
is known about the mechanisms that regulate the survival
and peritoneal metastases of shed cancer cells.
Spheroids can be created by culturing different cell lines
under conditions where their attachment to matrices is
hampered [5]. Such cellular manipulation has been used
mostly to understand the mechanism of drug resistance
that occurs with in vivo three-dimensional growth condi-
tions [6]. As a peritoneal model of metastasis, ovarian car-
cinoma spheroids have been shown to be protected from
apoptosis induced by radiation and common therapeutic
drugs such as Taxol [7]. This occurs due to the heteroge-
nous nature of cells within the spheroids, some of which
undergo phosphorylation of the anti-apoptotic protein
Bad under anchorage-independent settings. Recent stud-
ies have demonstrated the capacity of ovarian ascites
spheroids to dissaggregate on the mesothelial cells [8-10],
yet the mechanism of growth and in vitro phenotype of
spheroids remain uninvestigated.
The development of peritoneal metastases in ovarian car-
cinoma is regulated to a large extent by the adherence of
shed ovarian tumor cells, as spheroids, to the mesothelial
lining of the peritoneum, disaggregation of these cells
from the spheroid core and invasion into the extracellular
matrix (ECM) of the mesothelial layer. Both cell-cell adhe-
sion and cell-ECM interacting molecules play a role in this
process and a number of cell adhesion molecules have
been suggested [11]. The foremost important characteris-
tic of a multicellular tumor spheroid is to create an in vivo
tumor microenvironment that would allow cell-cell asso-
ciation. Hence, the formation of a spheroid depends
largely on the expression of certain cell-cell interacting
molecules which appear dramatically different in sphe-
roids compared to cells growing as a monolayer [12].
Although the expression of integrins has been studied in
various cultured cell lines growing as a monolayer, little is
known about the pattern of their expression in cells grow-
ing as spheroids. It has been suggested that the inhibition
of β1 integrin function can suppress tumor spheroid-ECM
interaction in ovarian cancer cell lines [8,13]. A variety of
other adhesion molecules have also been implicated in
the cell-ECM interaction. The interaction of CD44 to its
major ligand hyaluronic acid has been shown to regulate
the adherence of ovarian carcinomas to the mesothelium
in vitro [14] and in vivo [15]. CD44 demonstrates a similar
adhesive role in gastric and colon cancers [16,17]. Intrac-
ellular adhesion molecules (ICAM) have been shown to
modulate the adhesion of colon cancer cells to liver
endothelial cells [17] and a hepatoma cell line to mes-
othelial cells [18]. ICAM has also been shown to modu-
late the adhesion of a hepatoma cancer cell line to the
peritoneum [19]. Additionally, a role for the L1-adhesion
molecule in peritoneal growth and dissemination of ovar-
ian carcinoma has been recently reported [20]. These stud-
ies suggest that integrins and other adhesion molecules
play an important role in peritoneal dissemination of can-
cer cells and understanding such phenomena will help in
modulating spheroid growth for better therapeutic out-
comes.
An important component of tumor cell invasion involves
the enzymatic degradation of the ECM, allowing cancer
cells to penetrate the basement membrane and gain access
to vasculature to support secondary growth. A complex
mixture of proteolytic enzymes mediates this process,
including matrix metalloproteinases (MMPs) and serine
proteinases (such as urokinase plasminogen activator).
MMPs are zinc dependent proteinases and are capable of
degrading various ECM components such as collagen,
proteoglycans, gelatin, fibronectin, etc. MMPs promote
cancer progression by enhancing tumor cell growth,
migration, invasion, metastasis and angiogenesis [21].
The roles of MMP2 and MMP9 in the regulation of tumor
invasiveness and growth are well established in in vivo and
in vitro animal models [22]. Ovarian cancer cells express
MMP2 and MMP9, and we and others have shown that
increased expression of MMPs is associated with cancer
cell invasiveness and metastatic potential [23]. MMP2 and
9 are expressed in the ascites and plasma of ovarian cancer
patients [24]. Experimental studies have shown that ani-
mals bearing ovarian carcinoma xenografts in the perito-
neal cavity and treated with MMP inhibitors formed less
ascites and survived longer [21]. Moreover, stromal
MMP9 contributes to the malignant behavior of cancer
cells by promoting new vessel sprouting and tumor
growth through enhanced expression of VEGF [22]. These
studies suggest that MMP2 and MMP9 play an integral
role in the progression of ovarian cancer.Journal of Carcinogenesis 2007, 6:11 http://www.carcinogenesis.com/content/6/1/11
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In the present study, we have characterized the early
growth characteristics, adhesive, invasive and disaggrega-
tion capacity of HEY and OVHS1 ovarian cancer cell lines
grown as spheroids by a liquid-overlay technique. The
growth characteristics of a normal ovarian cell line
(IOSE29) grown in a similar fashion were also character-
ized. In order to determine if intrinsic differences existed
in the integrin profile, expressions of different integrin
subunits were compared in IOSE29, HEY and OVHS1 cell
lines grown as monolayers or as multicellular spheroids.
Antibody blockade was used to determine whether such
differences facilitate their disaggregation and invasive
capacity. Our results demonstrate that an important dif-
ference in integrin and MMP2/9 expression exists between
ovarian cancer cells grown as monolayers versus those
grown as spheroids and that function blocking mono-
clonal antibodies against α2 and β1 integrin subunits and
α2β1 integrin can block the disaggregation and MMP2/9
activation of ovarian carcinoma spheroids. Our findings
raise the possibility that α2β1 integrin may represent a
valuable therapeutic target in the suppression of intra-
peritoneal spread associated with the progression of ovar-
ian cancer.
Methods
Cell lines and Media
Two established ovarian cancer cell lines HEY and OVHS1
[25] were used in the study. The human ovarian surface
epithelial cell line (IOSE29) [26] transfected with SV-40
antigen was obtained from Dr Nelly Auersperg, University
of British Columbia, Canada. This cell line is not immor-
tal and can be maintained in culture for 17–20 passages.
ISOE29 cell line is not tumorigenic in mouse and mimics
normal ovarian cells in culture [26]. HEY and OVHS1 cell
lines were maintained and propagated in RPMI (St Louis,
MO, USA), while IOSE29 was cultured in Medium 199/
MCDB105 (1:1) (Sigma, St Louis, MO, USA). Both
medium were supplemented with 10% fetal bovine serum
and 2 mM glutamine (Sigma, St Louis, MO, USA). IOSE29
Cells were incubated at 37°C in 5% CO2 and routinely
checked for contamination. Viability was checked rou-
tinely by the Trypan blue exclusion method.
Antibodies and reagents
Monoclonal antibodies against integrin subunits α2
(clone P1E6), α3 (clone ASC-6), α6 (clone 4F10), αv
(clone AV1) and β1(clone P5D2) were obtained from
Chemicon International (Temecula, CA, USA). Mono-
clonal antibodies against cyclin D2, caspase-3 (4-1-18),
phospho-Akt and Akt were from Cell Signalling Technol-
ogy (Beverly, MA, USA). Antibody against Ki67 was from
DAKO Cytomation (Denmark). Phycoerythrin-conju-
gated goat anti-mouse IgG was obtained from Chemicon
International (Temecula, CA, USA). Horseradish peroxi-
dase-conjugated goat anti-mouse antibody was obtained
from Bio-Rad (Hercules, CA, USA) while HRP-conjugated
donkey anti-rabbit antibody was from Amersham Bio-
technology (UK). Fibronectin (FN), laminin (LM) and
collagen I (CI) were obtained from Sigma (St Louis, MO,
USA).
Human samples
The study was approved by the Research and Human Eth-
ics Committee (HEC#02/30, 02/29) of the Royal
Women's Hospital, Melbourne, Australia. Resected tissues
not required for clinical analyses were obtained from
patients who presented for surgery at the Royal Women's
Hospital, Melbourne, after the provision of a participant
information statement and only with informed consent.
Normal ovaries, needed for control comparisons were
removed from patients undergoing surgery as a result of
suspicious ultrasound images, palpable abdominal
masses and family history. Histological grading of ovarian
carcinoma was performed by two trained staff patholo-
gists using the method described by Silverberg [27].
Spheroid Culture
Spheroids were created using the liquid overlay technique
described previously [1]. Briefly, culture dishes or plates
were coated with 0.5%w/v agarose in serum free medium
(1:1) and allowed to dry for 30 min. Cells were released
from monolayer culture using 0.25% trypsin/0.2% EDTA
(JRH Biosciences™, Victoria, Australia), re-suspended in
normal medium and layered on agarose. The cultures
were maintained at 37°C, 5%CO2 for 6 h to 10 days.
Additional medium was added at day 7 to maintain nutri-
ent levels.
MTT assay
Spheroids were created in 12 well plates via the liquid
overlay technique described above. Six replica 12-well
plates were seeded with 5 × 104 cells, which were incu-
bated at 37°C, 5% CO2 until required for collection at
days 1, 2, 3, 4, 7, 8 or 10. On the day of collection, MTT
reagent (0.5 mg/ml) was added for 1.5 h. In monolayer
cultures, medium was removed from wells and 150 μl sol-
ubilizing buffer (1%w/v SDS, 90%v/v dimethyl sulphox-
ide) was used to dissolve the formazan crystals. For
spheroid cultures the formazan crystals were collected by
centrifugation (13,000 rpm, 10 min), dissolved in solubi-
lizing buffer and then transferred to 96 well microtitre
plates. Samples were read at OD595 nm on a Microplate
reader (BioRad Model 3550).
Immunohistochemistry
Spheroids grown in cell culture were harvested by centrif-
ugation then frozen in embedding medium (OCT) using
isopentane cooled in liquid nitrogen. Patient tissue was
similarly embedded in OCT and frozen in liquid nitrogen
cooled isopentane. Blocks were stored at -80°C. SectionsJournal of Carcinogenesis 2007, 6:11 http://www.carcinogenesis.com/content/6/1/11
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were cut at a 5 μm thickness and, if not required immedi-
ately, slides were stored at -20°C. For staining, sections
were fixed using cold acetone (4°C) for 15 min, trans-
ferred to Tris-buffered saline (TBS) pH 7.6, then incubated
for 1 h with primary antibody diluted in 1% w/v BSA/TBS.
Antibody binding was amplified using CHEMICON IHC
Select™ Immunoperoxidase Secondary Detection System
according to the manufacturer's instructions and visual-
ized using diaminobenzidine (DAB). Nuclei were coun-
terstained with Mayer's haematoxylin and an IgG1 isotype
was used as the negative control.
Sections were assessed microscopically for positive DAB
staining. Two observers (KS and CR) independently eval-
uated the immunostaining results. The concordance ratio
was > 95%. Differences of opinion were resolved by reach-
ing a consensus with the assistance of a third evaluator
(NA). Four sections were assessed per tissue and tissue
and cellular distribution of staining was determined. Par-
allel frozen sections were stained with hematoxylin and
eosin to confirm results.
Western blotting
Monolayer and spheroid cultures prepared as described
above were harvested, washed twice in PBS then snap fro-
zen in liquid N2 and stored at -80°C. Prior to sonication,
cells were re-suspended in a cell lysis buffer (10 mM Tris,
150 mM NaCl, 2 mM ethyleneglycol tetraacetic acid
(EGTA), 2 mM dithiolthreitol (DTT), 1 mM sodium
orthovanadate) supplemented with 1 μl/ml aprotinin and
10  μg/ml phenylmethylsulfonyl fluoride (PMSF). Cell
debris was the removed by centrifugation (13,000 rpm, 5
min) and supernatant stored at -20°C. Cell lysates con-
taining equal amounts of protein were resolved on 10%
or 15% SDS-PAGE gels under non-reducing conditions
and transferred to nitrocellulose membranes. Membranes
were probed with primary antibody followed by peroxi-
dase-labelled secondary antibody and visualised by
enhanced chemiluminescence (ECL) (Amersham, Buck-
inghamshire, UK) detection system according to the man-
ufacturer's instructions.
Adhesion assay
Adhesion assays were performed as described previously
[28]. Both normal and cancer cell lines grown as monol-
ayers were collected after trypsinization in medium con-
taining 1% serum. Spheroids were trypsinized, harvested
by centrifugation and re-suspended in the same medium
as the monolayer cells as a single cell suspension. Briefly,
1 × 104 cells were plated in triplicate on 96 well plates
coated with poly L lysine, FN, LM or CI (10 μg/ml) at
37°C for 90 min. Cells were then washed three times with
PBS to remove non-adhering cells and the adherent cells
were fixed with 100% methanol for 5 min at room tem-
perature. Cells were stained with 0.5% crystal violet for 15
min. Stained cells were washed with PBS, dried and
absorbance measured at 595 nm with Vmax plate reader
(Bio-Rad, Hercules, CA, USA).
Spheroid Adhesion and Migration Assay (Disaggregation)
Spheroids were grown in 92 cm dishes as described above.
The disaggregation assay was performed as described pre-
viously [8]. Briefly, 96-well plates coated with 10 μg/ml
FN, LM, CI or bovine serum albumin (BSA) were blocked
with BSA (1 mg/ml) for 2 h. Plates were washed with PBS
and spheroids suspended in serum-free RPMI medium
were layered on the wells at 5–10 spheroids per well.
Spheroids were sized and photographed at 1 h, 8 h and 24
h. The fold change in area was calculated by dividing the
pixel area of the spheroid at 8 and 24 h by the pixel area
at time 0.
Gelatin Zymography
Gelatin zymography was performed as described previ-
ously [29]. Briefly, serum-free medium, concentrated
using 10 kDa Amicon Ultra-4 spin columns and contain-
ing equal protein loads, was resolved on 10% Tris.HCl
acrylamide gels containing 0.1%w/v gelatin. The gel was
washed 5 times in zymogram wash buffer [Tris.HCl (pH
7.6), 5 mM CaCl2, 1 mM ZnCl2, 0.01% N3, 2.5% Triton X-
100] followed by 3 washes in incubation buffer [Tris.HCl
(ph 7.6), 5 mM CaCl2, 1 mM ZnCl2, 0.01% N3] then incu-
bated for 48 h at 37°C in incubation buffer before being
stained with coomassie blue (G-250) for visualization of
activation. After destain (30% methanol, 1% formic acid),
areas void of blue stain indicated areas of enzyme activity.
Molecular markers were used to identify pro-MMP2/9 and
MMP2/9.
Immunofluorescence
Cryostat sections were fixed in 4% paraformaldehyde,
permeablized in 0.1% Triton X-100, and blocked in 1%
BSA. Sections were probed with primary antibody (dilu-
tion 1/100 to 1/500) for 2 h followed by 1 h with Alexa
Fluor 488 labeled secondary. Sections were counter
stained with ethidium bromide (1/10,000) and coverslips
were mounted using Fluorgaurd© (BioRad Laboratories,
USA) and sealed with nail polish. Fluorescence was
imaged using a Leica TCS SP2 AOBS laser confocal micro-
cope (Leica, NSW, Australia) and associated software.
Flow cytometric analyses
Flow cytometric method was used as described previously
[23]. Briefly, monolayer and spheroid cultures of ovarian
cancer cell lines were collected and washed twice with
PBS. Spheroids were disintegrated into a single cell sus-
pension by 2–3 mins of trypsinization and repeated pipet-
ting. 106 cells were incubated with primary antibody for 1
h at 4°C and excess unbound antibody was removed by
washing twice with PBS. Cells were stained with second-Journal of Carcinogenesis 2007, 6:11 http://www.carcinogenesis.com/content/6/1/11
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(A) Formation of normal and ovarian carcinoma cell line spheroids over 10 days Figure 1
(A) Formation of normal and ovarian carcinoma cell line spheroids over 10 days. HEY, OVHS1 and IOSE29 cell lines at a density 
of 104cells/ml were seeded on 0.5% agarose-coated wells in the presence of normal growth medium for 10 days. Aggregation of 
cells was viewed using an inverted microscope with phase contrast, magnification 100 ×. (B) Proliferation of ovarian carcinoma 
cells grown as spheroids. HEY, OVHS1 and IOSE29 cells were seeded on agarose-coated plates as described in the Materials and 
Methods. The level of proliferation was measured by MTT assay as described in the Materials and Methods. Data are representa-
tive of three experiments expressed as mean ± SEM of twelve replicates. (C) Comparison of proliferation of IOSE29 (upper 
panel) and HEY (lower panel) cells grown as monolayer versus spheroids. Proliferation was measured by MTT assay as described 
above and data are expressed as mean ± SEM of six replicates. (D) Immunohistochemical staining of Ki67 in day 4 HEY and 
OVHS1 spheroids. Day 4 HEY and OVHS1 spheroids were collected, embedded in OCT, sectioned and stained as described in 
the Materials and Methods. Magnification 400 ×.
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ary antibody conjugated with phycoerythrin for 20 min at
4°C, washed twice with PBS and then re-suspended in 0.5
ml phosphate buffered saline (PBS) prior to FACScan
analysis. In each assay background staining was detected
using an antibody-specific IgG isotype. All data were ana-
lysed using Cell Quest software (Becton-Dickinson, Bed-
ford, MA, USA). Results are expressed as mean intensity of
fluorescence (MIF).
Statistical analysis
Student's t-test was used for statistical analyses of prolifer-
ation, adhesion, migration and invasion assays. Statistical
significance was indicated by p < 0.05. Data are presented
as mean ± SEM. Each experiment was repeated three times
with a minimum of three replicates.
Results
Spheroid formation and growth
Ovarian cancer cell lines HEY and OVHS1 and immortal-
ized ovarian surface epithelial (IOSE) cell line IOSE29
were analysed for formation of spheroids and subsequent
proliferation when maintained in a suspension culture.
Figure 1A illustrates spheroid formation and growth over
time and demonstrates that all three cell lines are able to
form spheroids. Within 24 h of seeding onto agarose-
coated plates, both normal and cancer cell lines clustered
and formed cellular aggregates of approximately 400–800
μm for the cancer cell lines and much smaller for the nor-
mal ovarian cell line. With time in culture, the cancer cells
became tightly packed, rounded and gradually increased
in size while the normal ovarian cell line IOSE29 gradu-
ally disintegrated, decreasing in size. Detailed morpholog-
ical analysis of OVHS1 and HEY spheroids using light
microscopy revealed that the spheroids of both cell types
formed well rounded, compact spheroids with defined
margins. On the other hand, cells within IOSE29 sphe-
roids dispersed and by day 10 were drastically reduced in
size indicating a characteristic of apoptosis.
Cellular growth of OVHS1, HEY and IOSE29 cell lines was
analysed using an MTT assay. In both cancer and normal
ovarian cell lines the growth of spheroids was significantly
reduced when compared to growth in traditional monol-
ayer culture (Figure 1C). On comparison of spheroid
growth only, HEY and OVHS1 spheroids showed a steady
increase in metabolic activity (Figure 1B, solid black and
grey lines respectively), while IOSE29 maintained only a
low level of activity (Figure 1B, dotted line). These data
indicate that while the normal ovarian cell line cannot
proliferate in suspension culture both ovarian cancer cell
lines were able to do so which is consistent with the
growth observed morphologically.
The specific ability of cells within the spheroids to con-
tribute to growth was subsequently confirmed using
immunohistochemical staining of Ki67 on OVHS1 and
HEY spheroid sections. Nuclear staining of Ki67, a stand-
ard histological marker for proliferation, identified a pop-
ulation of proliferating cells in spheroids of both OVHS1
and HEY cell lines (Figure 1D). These data suggest that
ovarian tumour spheroids are capable of maintaining a
proliferating population in suspension cultures.
Analysis of cell cycle mediators and pro/anti-apoptotic 
markers in spheroids
The ability of spheroid cultures to metabolize and prolif-
erate in culture was correlated by western blot analysis of
key mediators for cell cycle progression and pro/anti-
apoptotic proteins in spheroids collected at 0 (monolayer
control) and 6 h and 1, 2 and 4 days. The D-cyclins are
integral in early G1 to S phase transition in the cell cycle
[30]. The activation of protein kinase Akt/PKB and cas-
pase-3 play a central role in cell survival and apoptosis,
respectively [31-33]. The expression of cyclin D2 was sus-
tained in HEY spheroids but gradually decreased in
OVHS1 spheroids (Figure 2A). This is consistent with the
MTT response, which was lower in OVHS1 spheroids,
Expression of mediators for cell cycle progression, survival  and apoptosis in HEY and OVHS1 cell lysates obtained from  cells growing as monolayer or spheroids over 4 days Figure 2
Expression of mediators for cell cycle progression, survival 
and apoptosis in HEY and OVHS1 cell lysates obtained from 
cells growing as monolayer or spheroids over 4 days. Cell 
lysates were prepared and the expression of (A) cyclin D2, 
(B) P-Akt, T-Akt and (C) caspase-3 was determined by 
Western blotting as described in the Materials and Methods. 
Membranes from P-Akt immunostaining were stripped and 
re-probed for the expression of total Akt. (D) Total protein 
loading was determined by probing the membranes for β-
actin. The experiment is representative of three different 
experiments with similar results.
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compared to HEY spheroids. The activation of Akt was
maintained throughout the 4 days of spheroid growth in
both HEY and OVHS1 cultures (Figure 2B) while no acti-
vation of caspase-3 (Figure 2C) was observed in spheroids
of either cell line. These results suggest that both HEY and
OVHS1 spheroids are able to maintain their survival
response without the induction of ankiosis-dependent
apoptosis. Equal protein loading was confirmed for all
Western blots using β-actin staining (Figure 2D).
Spheroid Adhesion
In order for spheroids to contribute to cancer metastasis,
they must be able to adhere to the extracellular matrix
(ECM) of the peritoneal cavity. Compared to monolayer
cells, the adhesion of day 2 IOSE29 spheroids decreased
by approximately 50% or more (p < 0.05), while adhesion
of OVHS1 and HEY remained unchanged with no signifi-
cant differences on any of the ECM components (Figure
3). Similar results were observed for day 4 spheroids of
OVHS1 and HEY (data not shown) indicating sustained
adhesive capabilities despite being in suspension cultures
for up to 4 days.
Metastatic Potential
Peritoneal dissemination of ovarian cancer spheroids
occurs when cells within the free-floating spheroids attach
to the mesothelial lining of the peritoneum and disaggre-
gate, spreading to the secondary site. This process also
involves invasion, which requires proteolysis of ECM pro-
Disaggregation of HEY and OVHS1 spheroids on ECM Figure 4
Disaggregation of HEY and OVHS1 spheroids on ECM. HEY 
and OVHS1 cells were grown on 0.5% agarose for 4 days. 
Spheroids were collected and allowed to disaggregate on dif-
ferent ECM. (A) Morphological feature of disaggregation of 
HEY spheroids on CI after 24 h. (B, C) HEY and OVHS1 
cells grown as spheroids for 4 days were allowed to adhere 
and then disaggregated on BSA, CI, FN and LM and photo-
graphed at 1 (control), 8 and 24 h. The extent of disggrega-
tion was measured as described in Materials and Methods. 
Values shown represent the average fold change in pixel area 
of > 10 spheroids over 8 and 24 h from two experiments, ± 
SEM, *p < 0.05, significantly different from disaggregation on 
BSA.
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Adhesion of IOSE29, HEY and OVHS1 cell lines grown as  monolayer versus spheroids on different ECM Figure 3
Adhesion of IOSE29, HEY and OVHS1 cell lines grown as 
monolayer versus spheroids on different ECM. The adhesive 
response of cells grown as monolayer or as spheroids (day 2) 
on CI, FN and LM was determined as described in the Mate-
rials and Methods. Experiments on HEY and OVHS1 cells 
were repeated at least three times and performed in tripli-
cate. The experiment on IOSE29 cell line was repeated 
twice. Results are representative of one experiment per-
formed in triplicate, *significantly different from cells growing 
as a monolayer, p < 0.05.
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teins underlying the mesothelial layer. To understand if
cells within the spheroids exhibit such metastatic proper-
ties, spheroids were analyzed by in vitro disaggregation
assay on various ECM components. Similarly, a compari-
son of proteolytic activity of spheroids versus monolayer
cells was examined by testing the expression and activa-
tion of MMP2/9 using gelatin zymography.
OVHS1 and HEY spheroids began to transform from a
three-dimensional structure into flattened cell clusters
within 8 h. Figure 4A illustrates two disaggregating sphe-
roids after 24 h on a collagen coated plate. As the cells
migrated away from the core of the spheroid, cell-cell con-
tact was reduced and adherence and spreading on the
ECM constituents occurred. Within 24 h of cells attaching
to the ECM matrices (FN, LM and CI), both OVHS1 and
HEY spheroids (day 4) exhibited an increase in spheroid
disaggregation when compared to a BSA control. In HEY
spheroids, a significant increase in disaggregation was
observed as early as 8 h on all matrices tested, while for
OVHS1, only CI and LM facilitated significant disaggrega-
tion (p < 0.05).
Serum-free medium (SFM) was collected from monolayer
cells and cells grown as spheroids from day 1 to 7. In
monolayer cultures, only the expression of pro-MMP2/9
was observed whereas in spheroids the expression of
active MMP2 and MMP9 was induced and pro-MMP9
expression was replaced with active MMP9 (Figure 5A).
The identity of active MMP2 and MMP9 was determined
by treating SFM from a HEY monolayer culture with plas-
minogen (10 ng/ml) overnight. Plasminogen activated
pro-MMP9 (Figure 5B, lane 1) to active MMP9 (Figure 5B,
lane 2). On the other hand, inhibition of active MMP2
(Figure 5B, lane 3) was observed when SFM from day 2
HEY spheroid culture was treated with 1:10 phenanthro-
line (2 mM) overnight (Figure 5B, lane 4) [34]. In the
presence of phenanthroline no significant inhibition of
active MMP9 was observed. The identity of the 37 kDa
band in day 4 and 7 spheroids (Figures 5A and 5B) is not
Table 1: Expression of integrin subunits in OVHS1 and HEY cells growing as a monolayer and as spheroids for 4 days
Cell Type OVHS1 HEY
Integrin subunit Monolayer (MIF) Spheroid day 4 (MIF) Monolayer (MIF) Spheroid day 4 (MIF)
α2 509 ± 47 735 ± 41* 625 ± 40 886 ± 22*
α3 932 ± 60 905 ± 99 1107 ± 108 912 ± 112
αv 96 ± 1 114 ± 5 125 ± 14 120 ± 10
α6 661 ± 93 151 ± 18* 418 ± 45 208 ± 20*
β1 1302 ± 205 1340 ± 44 1224 ± 123 1072 ± 8
Values are expressed as mean intensity of fluorescence (MIF)
± SEM of three different readings obtained from independent experiments.
*Significantly different from cells growing as a monolayer (p < 0.05).
(A) Expression of secreted pro-MMP2/9 and MMP2/9 in the  cell free medium of HEY cell line grown as a monolayer or as  spheroids over 7 days Figure 5
(A) Expression of secreted pro-MMP2/9 and MMP2/9 in the 
cell free medium of HEY cell line grown as a monolayer or as 
spheroids over 7 days. Serum-free medium from the cells 
were collected and concentrated as described in the Materi-
als and Methods. 1 μg of protein from cells grown as a mon-
olayer and 0.5 μg of protein from spheroids was resolved on 
a 10% polyacrylamide gel supplemented with 1% gelatin. The 
experiment was repeated on OVHS1 cells with similar 
results. (B) Expression of secreted pro-MMP2/9 and MMP2/
9 activity in the cell free medium of HEY cell line grown as a 
monolayer in the absence or presence of plasminogen (10 ng/
ml, lanes 1 and 2 respectively) and as spheroids over 4 days 
in the absence or presence of 1:10 phenanthroline (2 mM, 
lanes 3 and 4 respectively).
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Flow cytometric analyses of α2 and α6 integrin subunits in HEY (A and B), OVHS1 (C and D) and IOSE29 (E and F) cells  grown as a monolayer and as spheroids (4 days for HEY and OVHS1 cells and 2 days for IOSE29 cells) Figure 6
Flow cytometric analyses of α2 and α6 integrin subunits in HEY (A and B), OVHS1 (C and D) and IOSE29 (E and F) cells 
grown as a monolayer and as spheroids (4 days for HEY and OVHS1 cells and 2 days for IOSE29 cells). Cells were incubated 
with either control IgG or primary α2 or α6 monoclonal antibody followed by secondary goat anti-mouse IgG conjugated with 
phycoerythrin. The mean intensity of fluorescence (MIF, arbitary units, log scale) was measured. The filled histogram in each 
figure is control IgG, black lines indicate the expression of protein in monolayer cells while broken lines demonstrate protein 
expression within the cells in spheroids. Results are representative of three independent experiments. Monolayer = mono, 
spheroid = SpJournal of Carcinogenesis 2007, 6:11 http://www.carcinogenesis.com/content/6/1/11
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known but has been observed by others in ovarian cancer
cells [35].
Cell surface expression of α-integrin subunits
Cell migration and invasion is facilitated by the cell-sur-
face expression of specific integrins. Expression of α2, α3,
α6, αv, and β1 integrin subunits was determined in sphe-
roids over 4 days of culture and compared to that of mon-
olayers. The expression of α3, αv and β1 integrin subunits
remained unchanged, however, a significant increase was
observed in the expression of α2 integrin within 24 h of
spheroid culture and there was a decrease in the expres-
sion of α6 integrin subunit expression over the 4 days of
culture (Table 1, Figure 6). Both HEY and OVHS1 cells do
not express β4 integrin subunit. The expression of α2, α3,
α6 and β1 integrin subunits was decreased in IOSE29 cells
by 1.5–7.5-fold within 2 days while the expression of αv
integrin subunit was sustained (Figure 6 and Table 2).
This is consistent with the significant loss of adhesion in
cells forming IOSE29 spheroids seen within 2 days as
described above. These data suggest that there is a differ-
ence in the modulation of integrin expression in sphe-
roids of cancer versus normal cells and that this explicit
difference may form the basis of longer survival of cancer
cells in anchorage independent conditions compared to
normal cells.
Cellular expression of α2 and α6 integrin subunits was
further investigated by confocal microscopy on spheroids
of OVHS1 cell line (Figure 7). Stronger expression of α2
integrin subunit was observed in the peripheral cells lin-
ing the outer layer of the spheroids (Figure 7A). On higher
magnification, expression of α2 integrin subunit was evi-
dent on the cell-cell interface (Figure 7B). In contrast, the
expression of α6 integrin was relatively low and diffuses
in localization (Figures 7C and 7D).
α2β1 integrin and spheroid proteolysis/disaggregation
To investigate if α2β1 integrin has any effect on the migra-
tion and proteolysis of spheroids, disaggregation and gel-
atin zymography analysis were performed in the presence
of blocking antibodies. Since α2β1 is a collagen receptor,
spheroid disaggregation was performed on CI- coated
plates using blocking antibodies against α2, β1 and α2β1.
Disaggregation of both OVHS1 and HEY spheroids (day
4) was significantly reduced by α2, β1 and α2β1 blocking
antibodies (p < 0.05) with the greatest inhibition seen in
the presence of anti-α2β1 integrin (Figure 8A). Under the
same blocking conditions the activation of MMP-2 was
also reduced (Figure 8B). The effect of inhibitory antibod-
ies on the activation of MMP9 under similar conditions
was difficult to discern because of the relatively high con-
centration of MMP9 in the medium. Taken together these
data indicate that α2β1 integrin may have a role in main-
taining the migration and invasive potential of spheroids.
Expression of α2 and α6 integrin subunits in normal 
ovaries, high-grade ovarian tumors and in patient's ascites
In the normal ovarian tissues (n = 10) the expression of
α2 and α6 integrin subunits was confined to the basal
layer of epithelial cells and displayed continuous labeling
(Figures 9A and 9B). Staining of endothelial cells lining
the blood vessels was also observed and in a few cases
stromal staining was also evident. Conversely, scattered
heterogeneous epithelial staining of α2 and α6 integrin
was observed in high-grade ovarian tumors (grade 3, n =
13, 10 serous, 1 endometrioid and 2 clear cell carcinoma
subtype) (Figures 9C and 9D). In all malignant tumors,
Cellular localisation of α2 and α6 integrin subunits in sphe- roids grown for 4 days Figure 7
Cellular localisation of α2 and α6 integrin subunits in sphe-
roids grown for 4 days. Using Alexa-fluor immunofluores-
cence, spheroids embedded in OCT were sectioned and 
stained for α2 and α6 integrin subunits and counterstained as 
described in the Materials and Methods. Images captured at 
magnification 400 × using an oil immersion lens on a Leica 
con-focal microscope. B and D are 1.5 × magnification of A 
and C respectively
OVHS1
A
B
C
D
α2 integrin 
subunit
α6 integrin 
subunit
Table 2: Expression of integrin subunits in IOSE 29 cells growing 
as a monolayer and as spheroids for 2 days
Integrin subunit Monolayer (MIF) Spheroid day 2 (MIF)
α2 830 ± 91 542 ± 142
α3 889 ± 69 335 ± 34*
αv 105 ± 84 95 ± 14
α6 1332 ± 171 176 ± 64*
β1 701 ± 84 294 ± 54*
Values are expressed as mean intensity of fluorescence (MIF)
± SEM of three different readings obtained from independent 
experiments.
*Significantly different from cells growing as a monolayer (p < 0.05).Journal of Carcinogenesis 2007, 6:11 http://www.carcinogenesis.com/content/6/1/11
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the basal reactivity of the epithelial layer was present in a
discontinuous fashion. Stromal staining as well as stain-
ing of endothelial cells was also evident in some tumor
sections.
Immunohistochemical staining of ascites smears (n = 4)
from high-grade ovarian cancer patients demonstrated
strong staining for α2 integrin subunits in clusters of
malignant cells. Some α6 subunit staining was present in
malignant cellular aggregates but it was weaker than α2
subunit staining. Weak staining of α2 and α6 subunits in
some single cells (epithelial cells, mesothelial cells,
inflammatory cells, etc) was also present. These results
suggest that α2 and α6 integrin is expressed by aggregates
of malignant cells present in ascites.
Discussion
Some recent studies have demonstrated that a significant
proportion of ovarian cancer cells in ascites exist as multi-
cellular aggregates and have the capacity to adhere and
invade the mesothelial cells lining the peritoneum [9,10].
Free floating multicellular aggregates or spheroids in the
ascites of cancer patients are difficult to isolate as they
break during purification and in some instances fail to
attach to and proliferate on a tissue culture substratum
[36]. Hence, to improve our understanding of spheroid
growth and spread with the perspective of developing
effective therapeutic targets for advanced-stage ovarian
cancer, we have developed an in vitro spheroid model
which mimics in vivo multicellular spheroids in the peri-
toneal effusions of women with ovarian cancer. The abil-
ity of spheroids to contribute to the spread of cancer has
been assessed by growth, adherence and disaggregation
capabilities and by investigating the profile of integrins
and MMP2/MMP9 that may mediate the dissemination
process. In some instances comparisons have been made
to a normal ovarian cell line grown under similar condi-
tions.
Cancer cell line spheroids resembled those present in the
ascites of cancer patients. Spheroids formed from ovarian
cancer cell lines increased in size with time, and formed
compact regular spheroid structures. As a product of
anchorage-independent culture, multicellular spheroids
had decreased proliferative abilities compared to the cells
cultured as monolayers. Hence, the monolayer cultures
approached confluence within seven days and decreased
proliferation, while the slower growing spheroids contin-
ued to grow for at least 10 days. This response was sup-
ported by staining for the proliferation marker Ki67,
which demonstrated the presence of proliferating cells
throughout both HEY and OVHS1 spheroids. In addition,
cancer cell line spheroids sustained activation of Akt,
expression of cyclin D2 and did not display any activation
of caspase-3. On the other hand, the normal ovarian cell
line (IOSE29) failed to proliferate under similar condi-
tions and its growth response was consistent with reduced
size and disintegration of spheroids with time. This dis-
parity in the response of normal versus cancer cell lines in
response to anchorage-independent surroundings reflects
major differences in the cohesive response required for
cell-cell contact in order to maintain survival. Expression
of Akt is amplified in many cancers, including ovarian
cancer [31]. Akt kinase activity is high in ovarian cancer
tissues and is associated with undifferentiated histology
Effect of blocking α2, β1 subunits and α2β1 integrin on (A)  disaggregation of 4 day spheroids on CI, and (B) MMP2/9  activation in HEY spheroids grown on 0 Figure 8
Effect of blocking α2, β1 subunits and α2β1 integrin on (A) 
disaggregation of 4 day spheroids on CI, and (B) MMP2/9 
activation in HEY spheroids grown on 0.5% agarose for 2 
days. To determine the neutralizing effect of antibodies sphe-
roids were treated with the antibodies (20 μg/500μl) for 30 
min before plating on CI for disaggregating assay. For gelatin 
zymography cells (106/ml) were treated with the antibodies 
(20 μg/ml) before seeding on 0.5% agarose in SFM fror 48 h. 
The experiment was repeated on OVHS1 cells with similar 
results.
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and aggressive clinical behaviour, suggesting that Akt con-
tributes to tumor progression [37]. Akt kinase promotes
cell survival by activating pro-apoptotic Bad, which in its
activated state binds anti-apoptotic agents, Bcl2 or Bclxl
that either on its own or together binds Bax, inhibiting the
release of cytochrome C from the mitochondria and acti-
vation of caspase-3 [38]. Therefore, by maintaining Akt
kinase activity, ovarian cancer spheroids inhibit caspase-3
activation and, subsequently, apoptosis.
We and others have shown that ovarian cancer cell lines
have the ability to adhere to ECM proteins such as FN, LM,
CI, etc [39]. Some studies have shown that spheroids gen-
erated from the NIH-OVCAR5 cell line can adhere to type
IV collagen, FN and LM [40] and adhesion levels of sphe-
roids isolated from patient's ascites were found to be
lower than single ovarian cancer cells growing in culture
[9]. Our results however, demonstrate no change in the
adhesion of cells within the HEY and OVHS1 spheroids
when compared to those growing as a monolayer. On the
other hand, the normal ovarian cell line (IOSE29) loses its
adhesive ability within 2 days, upon acquisition of sphe-
roid morphology. These differences in the adhesion of
normal versus cancer cells implicate differences in cell-
ECM interaction necessary for establishing a heterotypic
interaction with the matrix during the adhesion process.
The peritoneum, omentum and the bowel surfaces are the
frequent sites for implantation of metastatic ovarian can-
cer cells. The outer lining of these metastatic sites is com-
prised of a single layer of mesothelial cells, which express
a variety of ECM proteins, including LM, FN, CI and
hylauronan to which tumor cells can adhere before
spreading [13,41]. Significant increase in the disaggrega-
tion of ovarian cancer spheroids on different matrices
reflects the ability of cells within the spheroids to migrate
to distant sites. The differences in disaggregation observed
in the spheroids obtained from different cell lines, may
reflect variability in the expression of cell receptors and is
likely to be cell type specific.
In order for the spheroids to disseminate to a secondary
site they not only need to adhere, disaggregate and
migrate but they also need to invade the mesothelial cell
layer to form a stable secondary growth [36]. MMPs play
an important role in the invasion of cancer cells and are
involved in the degradation of ECM proteins allowing
cancer cells to migrate to a secondary site. We report that
ovarian cancer spheroids secrete much greater amounts of
both pro-MMP2 and MMP9 compared to cells grown as a
monolayer, and in the case of spheroids, both MMP2 and
MMP9 were present in the active form, while monolayer
cells only secreted the inactive precursors. These results
are consistent with the abundant amount of MMP2/
MMP9 reported in the ascites of ovarian cancer patients
[24] and are consistent with the previous study that
showed a blockade of spheroid invasion to mesothelial
monolayer in the presence of GM 6001, a broad-spectrum
matrix metalloproteinase inhibitor [8]. Recently, another
study has reported the invasive characteristics of sphe-
roids isolated from the ascites of ovarian cancer patients
and has correlated that invasiveness with a shortened sur-
vival of ovarian cancer patients by 16 to 17 months [10].
The same study also reported retraction of the mesothelial
layer at the site of spheroid attachment. This effect, how-
ever, disappeared by day 7, upon complete spheroid cell
dispersal, indicating that ascites tumor spheroids may be
involved in the degradation of mesothelial monolayer but
once disaggregated lose the capacity to do so. While we
have not shown invasion of a mesothelial monolayer by
spheroids, enhanced secretion of MMPs by HEY and
Expression of α2 and α6 integrin subunits in (A and B) nor- mal ovaries, (C and D) high-grade ovarian tumors and (E  and F) cellular aggregates present in a patient ascites Figure 9
Expression of α2 and α6 integrin subunits in (A and B) nor-
mal ovaries, (C and D) high-grade ovarian tumors and (E 
and F) cellular aggregates present in a patient ascites. Cryo-
stat sections of ovarian tissues and smears of ascites were 
stained by the immunoperoxidase method for the expression 
of α2 and α6 subunits as discussed in the Materials and Meth-
ods. (A and B) Normal ovaries, arrow showing continuous 
epithelial expression of α2 and α6 integrin subunits, (C and 
D) grade 3 serous ovarian tumors, arrows indicating irregu-
lar expression of α2 and α6 integrin subunits in epithelial 
cells; (E and F) arrows indicate cluster of epithelial tumor 
cells in a patient's ascites staining for α2 and α6 integrin sub-
units. Magnification 400 ×.
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OVHS1 spheroids, clearly implicates the greater invasive
capability of spheroids in vitro.
The biological mechanism(s) by which spheroids are
formed and sustained is not known. Both HEY and
OVHS1 cell lines express a variety of integrin receptors.
We report an enhanced expression of α2 and a decrease in
α6 integrin when comparing spheroidal cells to cells
grown as a monolayer, changes which were observable
within 24 hours. While the increased expression of α2 was
sustained in spheroids for 4 days, α6 expression gradually
decreased over the same period of time (data not shown).
On the other hand, no change in α3, αv and β1 subunits
were observed. In IOSE29 spheroids however, except αv,
there was a decrease in the expression of integrin subunits
ranging from 1.5–7.5-fold. These results were supported
by immunofluorescence studies performed on cancer
spheroids that displayed distinct high α2 subunit expres-
sion at the periphery of the spheroid and at the outer
membraneous layer forming the cell-cell interface of
aggregated cells. Very little or no α6 subunit staining was
evident in the cell-cell contact regions within the sphe-
roids suggesting very low expression. Based on these
observations one can conclude that cellular aggregation
and the environmental factors within the spheroids can
regulate the expression and localization of a specific sub-
set of integrins. Differences in the α2 and α6 integrin
expression between monolayer cells and spheroids how-
ever, had no effect on their adhesion capabilities on LM or
CI suggesting that α2 subunit up regulation may compro-
mise diminution of expression of α6 integrin subtype and
hence adhesion on LM. It is reasonable to speculate that
in a spheroid scenario it is more cell-cell rather than cell-
ECM interaction that will influence integrin expression
profile.
To assess if increased α2 expression had any effect on
spheroid function, spheroids were treated with blocking
antibodies for α2 and β1 subunits and α2β1 integrin and
then tested for disaggregation on CI-coated plates. Disag-
gregation was reduced for all three antibodies, with an
apparent accumulative inhibition occurring when α2β1
integrin function was blocked in comparison to individ-
ual α2 and β1 subunit function. Parallel to that, blocking
α2 and β1 subunits and α2β1 integrin also inhibited acti-
vation of MMP2, with no observable change in the expres-
sion of pro-MMP's. Although the specific participation of
individual integrins in spheroid phenotype is not under-
stood, our results suggest that α2β1 integrin may have a
role in the disaggregation and invasion of ovarian carci-
noma spheroids.
Selective regulation of integrin receptors in spheroids of
squamous cell carcinoma has been reported previously
[12]. In that study, the diminution of α6 and β1 integrin
subunit levels was observed in spheroids compared to
cells grown as a monolayer while no change in the expres-
sion of α2, α5 and β5 subunits was shown. Consistent
with that, the expression of α6 integrin has been shown to
be less in ovarian carcinoma effusions compared to that in
the tissues [42]. Recently, interaction between the α5β1
integrin and fibronectin has been shown to mediate the
formation of ovarian carcinoma spheroids [40]. In our
study we have not compared the expression of α5β1
integrin between monolayer cells and spheroids.
Strong expression of α2 and α6 integrin was observed at
the basal layer of surface epithelial cells of normal ovaries.
In ovarian tumors there was a loss of regular basement
membrane structure resulting in irregular staining of α2
and  α6 subunits. Intense staining of α2 integrin was
observed in ascites spheroids while staining of α6 subunit
occurred to a lesser degree. As α2β1 and α6β1 are the
major collagen and laminin receptors on basement mem-
branes, one can speculate that a tumor-induced irregular
pattern of matrix-modelling can result in the irregular dis-
tribution of these subunits in cancer. In ovarian carci-
noma, the expression of α6 subunit has been shown to
correlate with the expression of basement membrane pro-
tein laminin [42]. The same study also showed decreased
or loss of staining of laminin and α6 subunit in malignant
cells in ascites suggesting that laminin expression may reg-
ulate the expression of α6 integrin subunit [42]. The loss
of laminin in the ascites of patients may be due to less syn-
thesis of this basement membrane by tumor cells or may
be due to degradation by the proteolytic enzymes secreted
by the cells. This deficit in laminin may signal the tumor
cells to decrease their α6 subunit expression, consistent
with the gradual decrease in α6 subunit expression and
high proteolytic activity seen in spheroids.
The spread of ovarian carcinoma is unique as it involves
localized invasion and is rarely dependent on dissemina-
tion through lymphatics. In this context, the role of shed
tumor cells forming spheroids, implantation onto the
mesothelial lining of the peritoneum with consequent
disaggregation and dissemination is not well understood.
As little is known about the ascites tumor cell aggregates
or spheroids and the fact that these cells are often dis-
missed as non-metastatic and undergoing apoptosis is
somewhat disturbing. Better outcomes for ovarian cancer
patients can only be projected if a targeted approach can
be accomplished to disrupt the invasive processes of sphe-
roids requisite for peritoneal spread. Hence, a more com-
prehensive understanding of ascites spheroid biology is
needed to combat the dissemination of ovarian carci-
noma. In this study, we aimed to address this issue by
characterizing an in vitro model for the dissemination of
ovarian carcinoma. Using this model we were able to
show that α2β1 integrin is up regulated in the spheroidsJournal of Carcinogenesis 2007, 6:11 http://www.carcinogenesis.com/content/6/1/11
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and that functional blockade using monoclonal antibod-
ies reduced the extent of disaggregation and proteolysis of
spheroids. These data suggest that molecules that regulate
α2β1 integrin functions may have a potential role in
inhibiting the invasiveness of peritoneal tumor aggregates
or spheroids and may aid in suppressing the dissemina-
tion of ovarian carcinoma.
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